Jeisys Medical

What Jeisys Medical does

Jeisys Medical Inc., headquartered in Seoul, South Korea, is a manufacturer of energy-based medical aesthetic devices sold primarily to dermatology clinics, plastic surgeons, and aesthetic physicians across global markets. The company was founded in 2001 and operates through its principal office in the E-Land Gasan Building, Geumcheon-gu, Seoul, with a wholly-owned North American subsidiary (Jeisys US) and event-driven market development in APAC and LATAM. In September 2024, Jeisys was acquired by healthcare-focused private equity firm ArchiMed for $742 million, taking the previously KRX-listed entity private.

The core product platform comprises seven energy-based devices: DENSITY (monopolar/bipolar radiofrequency at 400W for skin tightening), POTENZA (radiofrequency with 14 tips — invasive and non-invasive — for acne and acne scarring), LinearZ (HIFU with Linear and Dot delivery modes for body contouring), D'Liv (microneedle drug delivery system), Cellec V (IPL with nine filters), TRI-BEAM (Nd:YAG laser for pigmentation and whitening), and Edge ONE 2.0 (CO2 laser for ablation). Additional branded offerings include INTRAcel, LinearFirm, ULTRAcel/ULTRAcel II, LIPOcel/LIPOcel II, AcGen, and IntraGen. Next-generation Alpha Tip consumables for the RF platform were showcased at KACAS 2026.

The revenue model is hardware-centric: capital equipment sales to medical aesthetic clinics via enterprise field sales (quote-based pricing, not publicly disclosed), supplemented by recurring consumables and accessories distributed through the medical-professional-only Jeisys Mall e-commerce storefront (mall.jeisys.com). Go-to-market relies on direct enterprise sales, dedicated regional websites (jeisys.com, jeisys-us.com), and aggressive participation in global industry events and proprietary symposia (Jeisys TEA Bangkok 2026, IMCAS Asia 2026, KACAS 2026, RADLA 2026, TEA Buenos Aires 2026). Customer segments are horizontal — dermatologists, plastic surgeons, and medical aesthetic clinics — with no public named customer logos.

Name

Jeisys Medical

Legal name

Jeisys Medical Inc.

Website

https://jeisys.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

101–250 employees

Short description

Jeisys Medical is a Seoul-based manufacturer of energy-based medical aesthetic devices (radiofrequency, HIFU, IPL, Nd:YAG laser, CO2 laser, and drug delivery systems) sold primarily to dermatologists, plastic surgeons, and aesthetic clinics worldwide; the company was acquired by PE firm ArchiMed in September 2024 for $742 million.

Ownership category

akta.pro rank

Product category

Medical Aesthetic Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Laser & Energy-Based Dermatology (HLAKACAF)

Keywords

• Medical aesthetic devices
• Energy-based devices
• Radiofrequency systems
• HIFU ultrasound devices
• IPL laser systems

Headquarters

HQ city

Seoul

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. Medical Aesthetic Devices: Sale of energy-based medical aesthetic devices including RF, HIFU, IPL, laser, and drug delivery systems for applications in body contouring, lifting, pigmentation, whitening, and acne/acne scar treatments.
2. Consumables: Sale of consumables and supplies through Jeisys Mall e-commerce platform (mall.jeisys.com), which is restricted to medical professional members.
3. Healthcare/Medical Aesthetics: The company was acquired by healthcare-focused private equity firm ArchiMed in September 2024 for $742 million, positioning the company in the broader medical aesthetics market.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Jeisys Medical designs, manufactures, and sells energy-based medical aesthetic devices for dermatology and plastic surgery clinics. Its core product line spans radiofrequency (DENSITY, POTENZA), HIFU (LinearZ), IPL (Cellec V), Nd:YAG laser (TRI-BEAM), CO2 laser (Edge ONE 2.0), and a Drug Delivery System (D'Liv), used for body contouring, skin lifting, pigmentation and whitening treatments, acne management, and acne scar revision. Revenue is generated through hardware sales of these devices plus related consumables distributed through medical-professional-only channels.

Product overview

Jeisys Medical offers a portfolio of energy-based medical aesthetic devices designed for non-invasive and minimally invasive cosmetic procedures. The product line includes seven core devices: DENSITY (monopolar/bipolar radiofrequency for skin tightening), POTENZA (fractionated radiofrequency microneedling for acne and scarring), LinearZ (HIFU for body contouring), D'Liv (microneedle drug delivery system), Cellec V (IPL for photorejuvenation), TRI-BEAM (Nd:YAG laser for pigmentation), and Edge ONE 2.0 (CO₂ laser for ablation). These devices address treatment categories including body contouring, lifting, pigmentation, whitening, acne, and acne scar management.

Differentiator

Problem solved

Functional benefit

Brands

• DENSITY: Radiofrequency (RF) device with monopolar and bipolar technology, maximum output of 400W, for skin tightening treatments
• POTENZA
• LinearZ
• D'Liv
• Cellec V
• TRI-BEAM
• Edge ONE 2.0
• DENSITY
• INTRAcel
• LinearFirm
• ULTRAcel
• ULTRAcel II
• LIPOcel
• LIPOcel II
• AcGen
• IntraGen

Products and services

• DENSITY Radiofrequency (RF) device delivering both monopolar and bipolar high-frequency technology that penetrates deep skin layers with a maximum output of 400W, primarily used for skin lifting and tightening procedures in clinics.
• POTENZA Radiofrequency (RF) device that delivers high-frequency energy to skin layers with a total of 14 tips in invasive and non-invasive configurations, used for acne treatment and pore/acne scar revision.
• LinearZ High-Intensity Focused Ultrasound (HIFU) device with a single cartridge delivering ultrasound energy to skin layers in two modes (Linear and Dot), with adjustable depth settings, designed for body contouring treatments.
• D'Liv Drug Delivery System (DDS) that uses fine needles to stimulate the skin and aid absorption of medications and topical treatments, supporting transdermal delivery for aesthetic procedures.
• Cellec V Intense Pulsed Light (IPL) device that aids in treating skin conditions by delivering light rays of various wavelengths using nine different filters, used for photorejuvenation and pigmentation indications.
• TRI-BEAM Nd:YAG laser device that destroys and removes interstitial chromophore, indicated for pigmentation and whitening treatments.
• Edge ONE 2.0 CO2 gas laser device that incises, destroys, and removes tissues and growths, used for skin resurfacing and surgical aesthetic procedures.

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• Cynosure (Hologic): Cynosure manufactures aesthetic laser, RF, and body-contouring systems (TempSure, Potenza rival, PicoSure) overlapping with Jeisys across multiple energy modalities, sold to the same dermatologist and plastic surgeon customer base.
• Alma Lasers (Sisram Medical): Alma is a global energy-based medical/aesthetic device company whose Soprano, Accent, and Harmony platforms compete with Jeisys across laser hair removal, RF body contouring, and IPL — sold into the same clinics in APAC and LATAM regions.
• Cutera, Inc. Cutera designs and markets lasers and energy-based aesthetic systems (truSculpt, excel V, Secret RF) directly overlapping with Jeisys' portfolio in body contouring, IPL, and RF microneedling for the same clinician customer.
• Lumenis (Boston Scientific): Lumenis is a pioneer in aesthetic and surgical laser/IPL platforms (M22, LightSheer, UltraPulse) that compete directly with Jeisys' TRI-BEAM Nd:YAG, Cellec V IPL, and Edge ONE CO2 laser. Same dermatology/aesthetic clinic channel and global enterprise sales motion.
• Candela Corporation: Candela (formerly Syneron) is a global medical aesthetic device company with overlapping laser, RF, and body-shaping systems (GentleLase, Vbeam, Embody) competing across Jeisys' product range for dermatologists and plastic surgeons worldwide.
• BTL Industries: BTL is a privately-held global manufacturer of non-invasive aesthetic and body-contouring devices (EMSCULPT, EMSELLA, Exilis) competing especially against Jeisys' LinearZ HIFU and LinearFirm/LIPOcel body contouring lines. Same enterprise clinic GTM and clinician customer.
• Sciton, Inc. Sciton manufactures aesthetic and medical laser/light platforms (BBL, Halo, Joule) directly competing with Jeisys' IPL (Cellec V) and laser resurfacing products. Targets the same dermatologist and plastic surgeon end users globally.
• InMode Ltd. InMode is a leading energy-based aesthetic and medical device manufacturer (BodyTite, Morpheus8, Evolve) competing across RF microneedling, body contouring, and HIFU-adjacent categories directly against Jeisys' POTENZA, DENSITY, and LinearZ. Same enterprise clinic channel and aesthetic clinician customer base.
• Solta Medical (Bausch Health): Solta is the maker of Thermage (monopolar RF skin tightening) and Fraxel (fractional laser) — the direct incumbent Jeisys' DENSITY competes against in the US skin-tightening category. Overlapping energy-based device portfolios, hospital/clinic channel, and aesthetic clinician end-customer make it the closest comp.

Emerging players

• Venus Concept: Venus Concept markets RF and IPL aesthetic platforms (Venus Versa, Venus Freeze) with overlapping use cases in skin tightening, body contouring, and photorejuvenation aimed at the same clinic customers, though with a smaller commercial footprint than the larger peers above.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xinstagram.com/jeisysmedical
• YouTubeyoutube.com/@%EC%A0%9C%EC%9D%B4%EC%8B%9C%EC%8A%A4%EB%A9%94%EB%94%94%EC%B9%BC
• Facebookfacebook.com/jeisysmedical
• Instagraminstagram.com/jeisysmedical

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries3 records

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Jeisys Medical